Trial Profile
Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2019
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Fluorouracil
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 25 Jun 2019 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified June 2017 ).
- 25 Jul 2017 New trial record